Hyaluronic acid/poly(amidoamine) dendrimer nanoparticles for central nervous system applications: in vitro and in vivo studies

Central nervous system (CNS) disorders are among the diseases with less efficiency in treatment. In order to reach its target and exert its effect within the brain parenchyma, drugs must overcome the blood brain barrier (BBB) and the blood-cerebrospinal fluid-brain (BCSFB). The aim of this work was...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva, Barbara L. (author)
Outros Autores: Cerqueira, Susana R. (author), Fevereiro, J. P. (author), Pirraco, Rogério P. (author), Marques, A. P. (author), Oliveira, Joaquim M. (author), Reis, R. L. (author), Sousa, Nuno (author), Salgado, A. J. (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2012
Assuntos:
Central nervous system applications
Dendrimer nanoparticles
Science & Technology
Texto completo:http://hdl.handle.net/1822/23867
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/23867

Texto Completo

http://hdl.handle.net/1822/23867

Registros relacionados